Skip to main navigation Skip to search Skip to main content

Refining mild asthma phenotyping with FeNO: a population-based evaluation

  • Charmaine J. M. Lim*
  • , Marie-Kathrin Breyer
  • , Emiel F. M. Wouters
  • , Robab Breyer-Kohansal
  • *Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Abstract

The utility of fractional exhaled nitric oxide (FeNO) was evaluated alongside blood eosinophils in phenotyping mild asthma. Inclusion of FeNO improved classification accuracy and calibration in an adapted ISAR-based model; however, its predictive improvement was modest and its susceptibility to transient elevations suggests limited added value for routine clinical classification. Simplified algorithms may offer more accurate phenotyping in population-based settings with real-world constraints.
Original languageEnglish
Article number47
Number of pages5
Journalnpj Primary Care Respiratory Medicine
Volume35
Issue number1
DOIs
Publication statusPublished - 27 Oct 2025

Keywords

  • EXHALED NITRIC-OXIDE
  • EXACERBATIONS

Fingerprint

Dive into the research topics of 'Refining mild asthma phenotyping with FeNO: a population-based evaluation'. Together they form a unique fingerprint.

Cite this